Low Dose Ketamine (LDK) Versus Morphine for Acute Pain Control in the Emergency Department
Status:
Completed
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the safety and effectiveness of intravenous low dose
ketamine (LDK) to the industry standard of morphine (MOR) in regards to controlling acute
pain in the emergency department.
Both LDK and morphine have side effects. The amount and character of these side effects will
be compared. Additionally, the degree of sedation or agitation will be specifically measured.
The aim of this current study is to make this comparison and shift the evidence for LDK use
from the anecdotal to the scientific.